VJET

SEC source: 0001209191-19-031485 · doc4.xml · nonDerivative · entry 1

FOGARTY THOMAS G · CIK 0001242932 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,894

F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3 of the total number of shares underlying the RSUs granted will vest on May 20, 2020, and 1/6th of the total number of shares underlying the RSUs will vest on each November 20 and May 20 thereafter, such that the Award will be fully vested on May 20, 2022; provided, however, that if a vesting date would otherwise fall on a day when the national stock exchange upon which the shares are listed is not open for trading, vesting will occur on the first trading day thereafter. Vesting in all instances is subject to the Reporting Person's continuous status as a Service Provider (as defined in the 2018 Equity Incentive Plan) through each vesting date.

SEC source: 0001209191-19-029699 · doc4.xml · nonDerivative · entry 2

Irwin Dean · CIK 0001746687 · Director · See Remarks · 10% owner

Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 132,838

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.7952 to $3.8254 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-19-029699 · doc4.xml · nonDerivative · entry 1

Irwin Dean · CIK 0001746687 · Director · See Remarks · 10% owner

Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 221,212

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.7989 to $3.8291 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-19-024606 · doc4.xml · nonDerivative · entry 2

Irwin Dean · CIK 0001746687 · Director · See Remarks · 10% owner

Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 141,084

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

SEC source: 0001209191-19-024606 · doc4.xml · nonDerivative · entry 1

Irwin Dean · CIK 0001746687 · Director · See Remarks · 10% owner

Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,948

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

SEC source: 0001209191-18-059277 · doc4.xml · nonDerivative · entry 1

Horwood Daniel · CIK 0001756566 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,641

F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3 of the total number of shares underlying the RSUs granted will vest on November 20, 2019, and 1/6th of the total number of shares underlying the RSUs will vest on each May 20 and November 20 thereafter, such that the Award will be fully vested on November 20, 2021; provided, however, that if a vesting date would otherwise fall on a day when the national stock exchange upon which the shares are listed is not open for trading, vesting will occur on the first trading day thereafter. Vesting in all instances is subject to the Reporting Person's continuous status as a Service Provider (as defined in the 2018 Equity Incentive Plan) through each vesting date.

SEC source: 0001209191-18-054441 · doc4.xml · nonDerivative · entry 1

ENQUIST WILLIAM R · CIK 0001659002 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,235

F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3rd of the RSUs shall vest annually beginning on October 4, 2019 such that the RSUs will be fully vested on October 4, 2021, subject to the reporting person's continued service.

SEC source: 0001209191-18-054443 · doc4.xml · nonDerivative · entry 1

Mejia Richard Jr · CIK 0001445578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,235

F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3rd of the RSUs shall vest annually beginning on October 4, 2019 such that the RSUs will be fully vested on October 4, 2021, subject to the reporting person's continued service.

SEC source: 0001209191-18-054435 · doc4.xml · nonDerivative · entry 1

Saad Mark E · CIK 0001295913 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,235

F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3rd of the RSUs shall vest annually beginning on October 4, 2019 such that the RSUs will be fully vested on October 4, 2021, subject to the reporting person's continued service.

SEC source: 0001209191-18-054437 · doc4.xml · nonDerivative · entry 1

BUCHBINDER MAURICE · CIK 0001270178 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,625

F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3rd of the RSUs shall vest annually beginning on October 4, 2019 such that the RSUs will be fully vested on October 4, 2021, subject to the reporting person's continued service.

SEC source: 0001209191-18-054439 · doc4.xml · nonDerivative · entry 1

COLOMBATTO MARTIN J · CIK 0001208236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,625

F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3rd of the RSUs shall vest annually beginning on October 4, 2019 such that the RSUs will be fully vested on October 4, 2021, subject to the reporting person's continued service.